1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > World In-vitro Fertilization (IVF) - Market Opportunities and Forecasts, 2014 - 2021

IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.The global IVF market is expected to reach $11.3 billion by 2021, at a CAGR of 7.0% from 2015 to 2021. Reduction in conception rates mainly in women aged 40 years or above, delayed pregnancy in women suffering from gynecological conditions, changing lifestyle and fertility disorders are the major factors that drive the market growth. Other factors responsible for the market growth are favorable reimbursement scenario and the delayed parenthood opted by couples due to professional and financial constraints. On the other hand, ethical concerns in particular countries, high cost of the IVF procedures and low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.The rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.To provide a detailed market assessment, the report segments the global IVF market on the basis of end-users and geography. The end-users IVF market is categorized into fertility clinics, hospitals, surgical centres and clinical research institutes. Fertility clinics and hospitals were the leading end-user segments globally, accounting for around three-fourths of the market in 2014.Geographically, the market is segmented across North America, Europe, Asia Pacific and LAMEA regions. In terms of number of IVF cycles performed, the Asia-Pacific region dominates the global IVF market. Asia Pacific IVF market is set to grow at a promising CAGR of 8.9% from 2015 to 2021, due to the factors such as wide availability of IVF clinics, high IVF success rates and the rising trend of fertility tourism. In Asia-Pacific region, China is the leading country accounting for majority of the market share and is expected to maintain its position during the analysis period. In terms of revenue, North America dominates the global IVF market, owing to the favorable reimbursement scenario. The market is expected to reach around $4.0 billion by 2021, at a CAGR of 7.9% over the forecast period.KEY MARKET BENEFITS:The report provides an in-depth analysis of the IVF market across twenty major countries with a cross sectional analysis of the number of IVF cycles performed, and total revenue generated during the forecast period The report helps in understanding the strategies adopted by various IVF clinics and hospitals in particular countries, in order to gain market share in the global IVF service marketRegion-wise and country-wise IVF market is comprehensively analyzed in the report The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2014‐2021, in terms of value and volumeExtensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework

KEY MARKET SEGMENTS
:The global IVF market is segmented on the basis of end-users and geography:Global IVF Market ‐ By End Users  (Value and Volume)Fertility ClinicsHospitalsSurgical centersClinical research institutesGlobal IVF Market ‐ By End User Country Level Analysis (Value and Volume) United StatesCanadaMexicoUnited KingdomGermanyFranceItalySpainDenmarkRussiaOthers  EuropeChinaIndiaJapanAustraliaNew ZealandKoreaThailandOthers APACLatin AmericaMiddle EastAfrica Global IVF Market ‐ By Geography (Value and Volume)North AmericaUnited StatesCanadaMexicoEuropeUnited KingdomGermanyFranceItalySpainDenmarkRussiaOthers  EuropeAsia-PacificChinaIndiaJapanAustraliaNew ZealandKoreaThailandOthers APACLAMEALatin AmericaMiddle EastAfrica

Table Of Contents

World In-vitro Fertilization (IVF) - Market Opportunities and Forecasts, 2014 - 2021
CHAPTER: 1 INTRODUCTION1.1 Report Description1.2 Key Benefits1.3 Key Market Segments1.4 Research Methodology1.4.1 Secondary research1.4.2 Primary research1.4.3 Analyst tools and modelsCHAPTER: 2 EXECUTIVE SUMMARYCHAPTER: 3 GLOBAL IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW3.1 Market Definition and Scope3.2 IVF pricing trends by country3.3 IVF Cycles by Country3.4 Global IVF Market by End Users3.5 Market Dynamics3.5.1 Drivers3.5.1.1 Delayed pregnancies in women3.5.1.2 Rise in global infertility rates3.5.1.3 Emergence of new fertility tourism destinations3.5.2 Restraints3.5.2.1 Cost involved in the treatment3.5.2.2 Low level of awareness in developing economies3.5.2.3 Inadequate reimbursements policies for IVF treatments3.5.2.4 Ethical Considerations3.5.3 Opportunities3.5.3.1 Market growth by relaxing the legal considerations3.5.3.2 New technology development and treatment options3.5.3.3 Three parent IVF3.6 Key FindingsCHAPTER: 4 NORTH-AMERICA IVF MARKET4.1 United States IVF Market, (revenue and Number of Cycles)4.1.1 Number of IVF Cycles, 2014-20214.1.2 United States IVF Market, 2014-2021 ($Million)4.1.3 Number of Infertility Clinics, 20144.2 United States IVF Market by End Users4.2.1 Market Dynamics4.2.1.1 Drivers4.2.1.1.1 INCREASING POPULARITY OF IVF IN UNITED STATES4.2.1.1.2 INCREASED RATE OF INFERTILITY AND PRACTICES OF EMBRYO BANKING CYCLES4.2.1.2 Restraints4.2.1.2.1 HIGH COST OF IVF IN UNITED SATES4.2.1.2.2 BAN ON 3-PARENT IVF4.2.1.2.3 SCATTERED REIMBURSEMENTS4.2.2 Regulatory Issues, Legislations and Authorities4.2.3 Insurance Reimbursement Scenario4.2.4 Company Profile4.2.4.1 Fertility and Gynecology Center Monterey Bay IVF4.2.4.2 Conceptions Reproductive Associates4.2.4.3 Servy Massey Fertility Institute4.2.4.4 Sher Institute for Reproductive Medicine (SIRM)4.2.4.5 Cardone Reproductive Medicine andamp; Infertility4.2.4.6 Fertility Center of San Antonio4.2.4.7 Houston Fertility Center4.2.4.8 New hope fertility center4.2.4.9 Reproductive Medicine Associates Of New Jersey4.3 Canada IVF Market (Revenue and Number of Cycles)4.3.1 Number of IVF Cycles, 2014-20214.3.2 Canada IVF Market, 2014-2021 ($Million)4.3.3 Number of infertility centres4.4 Canada IVF Market by End users4.4.1 Market Dynamics4.4.1.1 Drivers4.4.1.1.1 COMMERCIALIZATION OF IVF BOOSTER IN CANADA4.4.1.2 Restraints4.4.1.2.1 HIGH COST OF IVF IN CANADA4.4.2 Regulatory Issues, Legislations and Authorities4.4.3 Insurance Reimbursement Scenario4.4.4 Company Profile4.4.4.1 Toronto Centre for Advanced Reproductive Technology Ltd.4.4.4.2 Fertility Treatment Center4.4.4.3 Montreal Fertility Center4.5 Mexico IVF Market (Revenue and Number of Cycles)4.5.1 Number of IVF Cycles, 2014-20214.5.2 Mexico IVF Market, 2014-2021 ($Million)4.5.3 Number of infertility centres4.6 Mexico IVF Market by End Users4.6.1 Market Dynamics4.6.1.1 Drivers4.6.1.1.1 FERTILITY TOURISM4.6.1.1.2 COMPARATIVELY LOW COST OF IVF4.6.1.2 Restraints4.6.1.2.1 LANGUAGE BARRIERS4.6.2 Regulatory Issues, Legislations and Authorities4.6.3 Insurance Reimbursement Scenario4.6.4 Company Profile4.6.4.1 Liv Fertility Center In Puerto Vallarta4.6.4.2 BFC Biofertility CenterCHAPTER: 5 EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)5.1 Germany IVF Market (Revenue and Number of Cycles)5.1.1 Number of IVF Cycles, 2014anddash;20215.1.2 Germany IVF Market, 2014anddash;2021 ($Million)5.1.3 Number of infertility clinics5.2 Germany IVF Market by End Users5.2.1 Market Dynamics5.2.1.1 Drivers5.2.1.1.1 SUBSIDIZING IVF TREATMENTS5.2.1.1.2 DELAYED MARRIAGES AND PARENTHOOD DECISIONS5.2.1.2 Restraints5.2.1.2.1 STRINGENT GOVERNMENT REGULATIONS5.2.1.2.2 LACK OF AVAILABILITY IN TREATMENT CYCLES FOR IVF5.2.2 Regulatory Issues, Legislations and Authorities5.2.3 Insurance Reimbursement Scenario5.2.4 Company Profile5.2.4.1 Heidelberg University Hospital5.2.4.2 Klinikum Stuttgart5.2.4.3 DRK Kliniken Berlin5.2.4.4 University Medical Center Freiburg5.3 France IVF Market (Revenue and Number of Cycles)5.3.1 Number of IVF Cycles, 2014anddash;20215.3.2 France IVF Market, 2014anddash;2021 ($Million)5.3.3 Number of infertility centers5.4 France IVF Market by End Users5.4.1 Market Dynamics5.4.1.1 Drivers5.4.1.1.1 SAME GENDER ADOPTION OF IVF BABIES5.4.1.1.2 LOWER RATES OF FERTILITY5.4.1.2 Restraints5.4.1.2.1 STRINGENT GOVERNMENT REGULATIONS5.4.2 Regulatory Issues, Legislations and Authorities5.4.3 Insurance Reimbursement Scenario5.4.4 Company Profile5.4.4.1 Clinique de la Muette5.4.4.2 Hopital des metallurgists, hopital cochin5.5 United Kingdom IVF Market (Revenue and Number of Cycles)5.5.1 Number of IVF Cycles, 2014anddash;20215.5.2 United Kingdom IVF Market, 2014anddash;2021 ($Million)5.5.3 Number of infertility centers5.6 United Kingdom IVF Market by End Users5.6.1 Market Dynamics5.6.1.1 Drivers5.6.1.1.1 COMMERCIALIZATION OF THREE-PARENT IVF PROCEDURES5.6.1.1.2 SUPPORTIVE REGULATIONS5.6.1.2 Restraints5.6.1.2.1 ETHICAL CONSIDERATIONS5.6.2 Regulatory Issues, Legislations and Authorities5.6.3 Insurance Reimbursement Scenario5.6.4 Company Profile5.6.4.1 Lister Fertility Clinic5.6.4.2 The Bridge Center5.6.4.3 Chelsea and Westminster Hospital (Assisted Conception Unit)5.7 Italy IVF Market (Revenue and Number of Cycles)5.7.1 Number of IVF Cycles, 2014anddash;20215.7.2 Italy IVF Market, 2014anddash;2021 ($Million)5.8 Italy IVF market by End users5.8.1 Market Dynamics5.8.1.1 Drivers5.8.1.2 Restraints5.8.1.2.1 BAN ON THE SURROGACY5.8.2 Regulatory issues, legislations and authorities5.8.3 Insurance Reimbursement Scenario5.8.4 Company Profile5.8.4.1 ARC-STER srl5.8.4.2 RAPRUI5.8.4.3 Centre for Reproductive Medicine-Napoli5.9 Spain IVF Market (Revenue and Number of Cycles)5.9.1 Number of IVF Cycles, 2014anddash;20215.9.2 Spain IVF Market, 2014anddash;2021 ($Million)5.10 Spain IVF Market by End Users5.10.1 Market Dynamics5.10.1.1 Drivers5.10.1.1.1 INCREASE IN THE NUMBER OF FOREIGN PATIENTS5.10.1.2 Restraints5.10.2 Regulatory Issues, Legislations and Authorities5.10.3 Insurance Reimbursement Scenario5.10.4 Company Profiles5.10.4.1 IVF spain5.10.4.2 Clandiacute;nica EUGIN Barcelona5.11 Denmark IVF Market (Revenue and Number Of Cycles)5.11.1 Number of IVF Cycles, 2014anddash;20215.11.2 Denmark IVF Market, 2014anddash;2021 ($Million)5.12 Denmark IVF Market by End Users5.12.1 Market Dynamics5.12.1.1 Drivers5.12.1.1.1 INCREASE IN DISPOSABLE INCOME5.12.1.1.2 ADVANCES IN IVF TECHNOLOGY5.12.1.2 Restraints5.12.1.2.1 INADEQUATE REIMBURSEMENT POLICIES5.12.2 Regulatory Issues, Legislations and Authorities5.12.3 Insurance Reimbursement Scenario5.12.4 Company Profiles5.12.4.1 Copenhagen Fertility Center5.12.4.2 Storkklinik v/Nina Stork5.12.4.3 Vitanova5.12.4.4 trianglen fertility clinic5.12.4.5 Nordica - Denmark, Copenhagen5.13 Russia IVF Market (Revenue annd Number of Cycles)5.13.1 Number of IVF Cycles, 2014anddash;20215.13.2 Russia IVF Market, 2014anddash;2021 ($Million)5.14 Russia IVF Market by End Users5.14.1 Market Dynamics5.14.1.1 Drivers5.14.1.1.1 RISING POPULARITY OF FERTILITY TOURISM5.14.1.2 Restraints5.14.1.2.1 INADEQUATE REIMBURSEMENT POLICIES5.14.2 Regulatory Issues, Legislations and Authorities5.14.3 Insurance Reimbursement Scenario5.14.4 Company Profiles5.14.4.1 ava-peter clinic5.14.4.2 md medical group5.14.4.3 ivf russia (The International Centre of the Reproductive Medicines)5.15 Other Europe IVF Market (Revenue and Number of Cycles)5.15.1 Number of IVF Cycles, 2014anddash;20215.15.2 Other Europe IVF Market, 2014anddash;2021 ($Million)5.16 Other Europe IVF Market by End Users5.16.1 Market Dynamics5.16.1.1 Drivers5.16.1.1.1 WIDE AVAILABILITY OF REIMBURSEMENTS5.16.1.1.2 EMERGENCE OF NEW FERTILITY DESTINATIONS5.16.1.1.3 CHANGES IN LIFESTYLE5.16.1.2 Restraints5.16.2 Regulatory Issues, Legislations and Authorities5.16.3 Insurance Reimbursement Scenario5.16.4 Company Profiles5.16.4.1 Gynaecoloqisch Centrum5.16.4.2 centrum voor medische genetica5.16.4.3 Infertility-Vandauml;estandouml;liittoCHAPTER: 6 ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)6.1 India IVF Market (Revenue and Number of Cycles)6.1.1 Number of IVF Cycles, 2014anddash;20216.1.2 India IVF Market, 2014anddash;2021 ($Million)6.2 India IVF Market by End Users6.2.1 Market Dynamics6.2.1.1 Drivers6.2.1.2 Restraints6.2.2 Regulatory Issues, Legislations and Authorities6.2.3 Insurance Reimbursement Scenario6.2.4 Company Profile6.2.4.1 Sun Pharmaceutical6.2.4.2 Trivector Origio Scientific Pvt. Ltd6.2.4.3 LabIVF Asia Pte. Ltd6.2.4.4 LG Life Sciences.6.2.4.5 Cadila Healthcare Ltd.( Zydus Cadila group)6.2.4.6 Bourn Hall Clinic6.2.4.7 Southend Fertility and IVF Centre6.2.4.8 Morpheus IVF Fertility Center6.2.4.9 Bloom Fertility Center6.2.4.10 Manipal Ankur6.2.4.11 Cloudnine6.2.4.12 Nova IVI Fertility6.3 China IVF Market (revenue and number of cycles)6.3.1 Number of IVF Cycles, 2014anddash;20216.3.2 China IVF Market, 2014anddash;2021 ($Million)6.4 China IVF Market by End User6.4.1 Market Dynamics6.4.1.1 Drivers6.4.1.1.1 INCREASED RATE OF INFERTILITY6.4.1.1.2 CHANGE IN LIFESTYLE6.4.1.2 Restraints6.4.1.2.1 COST OF LIVING6.4.1.2.2 ONE CHILD POLICY6.4.2 Regulatory Issues, Legislations and Authorities6.4.3 Insurance Reimbursement Scenario6.4.4 Company profile6.4.4.1 Cook Medical, Inc.6.4.4.2 Vitrolife AB6.4.4.3 Reproductive and genetic Hospital Citic-Xiangya6.4.4.4 Shenyang Hospital6.4.4.5 Shandong Provincial Hospital6.4.4.6 Centre for Reproductive Medicine6.5 Japan IVF Market (Revenue annd Number Of Cycles)6.5.1 Number of IVF Cycles, 2014anddash;20216.5.2 Japan IVF Market, 2014anddash;2021 ($Million)6.6 Japan IVF Market by End-Users6.6.1 Market Dynamics6.6.1.1 Drivers6.6.1.2 Restraints6.6.2 Regulatory Issues, Legislations and Authorities6.6.3 Insurance Reimbursement Scenario6.6.4 Company Profile6.6.4.1 EMD Serono, Inc6.6.4.2 IVF NAMBA Clinic6.6.4.3 Iwaki Womenandrsquo;s Clinic6.6.4.4 Sanno Hospital6.7 Australia IVF Market (Revenue annd Number Of Cycles)6.7.1 Number of IVF Cycles, 2014anddash;20216.7.2 Australia IVF Market, 2014anddash;2021 ($Million)6.8 Australia IVF Market by End Users6.8.1 Market Dynamics6.8.1.1 Drivers6.8.1.2 Restraints6.8.1.2.1 EMOTIONAL AND PHYSICAL STRESS6.8.1.2.2 NO GUARANTEE FOR THE SUCCESSFUL TREATMENTS6.8.1.2.3 SURPLUS EMBRYOS6.8.2 Regulatory Issues, Legislations and Authorities6.8.3 Insurance Reimbursement Scenario6.8.4 Company Profile6.8.4.1 Genea Biomedx6.8.4.2 Thermo Fisher Scientific Inc.6.8.4.3 Virtus Health limited6.8.4.4 Monash IVF6.8.4.5 City Fertility center, brisbane6.8.4.6 Flinders Fertility clinic6.9 New Zealand IVF Market (Revenue and Number of Cycles)6.9.1 Number of IVF Cycles, 2014anddash;20216.9.2 New Zealand IVF Market, 2014anddash;2021 ($Million)6.10 New Zealand IVF Market by End users6.10.1 Market Dynamics6.10.1.1 Drivers6.10.1.2 Restraints6.10.2 Regulatory Issues, Legislations and Authorities6.10.3 Insurance Reimbursement Scenario6.10.4 Company Profiles6.10.4.1 Fertility Associates6.10.4.2 Fertility Plus6.10.4.3 Repromed6.11 Korea IVF Market (Revenue and Number of Cycles)6.11.1 Number of IVF Cycles, 2014anddash;20216.11.2 Korea IVF Market, 2014anddash;2021 ($Million)6.12 Korea IVF Market by End Users6.12.1 Market Dynamics6.12.1.1 Drivers6.12.1.2 Restraints6.12.2 Regulatory Issues, legislations and Authorities6.12.3 Insurance Reimbursement Scenario6.12.4 Company Profiles6.12.4.1 Cha General Hospital6.12.4.2 MARIA Fertility Hospital6.13 Thailand IVF Market (Revenue and number of Cycles)6.13.1 Number of IVF Cycles, 2014anddash;20216.13.2 Thailand IVF Market, 2014anddash;2021 ($Million)6.14 Thailand IVF Market by End Users6.14.1 Market Dynamics6.14.1.1 Drivers6.14.1.1.1 GOVERNMENT INITIATIVES6.14.1.1.2 ECONOMICAL CONSIDERATIONS6.14.1.1.3 BOOST IN MEDICAL TOURISM6.14.1.2 Restraints6.14.1.2.1 COMPARATIVELY LOW SUCCESS RATE6.14.1.2.2 ETHICAL ISSUES IN ALLOWING GENDER SELECTION6.14.2 Regulatory Issues, legislations and Authorities6.14.3 Insurance Reimbursement Scenario6.14.4 Company Profiles6.14.4.1 Bangkok Fertility Center6.14.4.2 Siriraj Hospital6.14.4.3 Ramathibodi Hospital6.14.4.4 Perfect Woman Institute6.14.4.5 Jetanin Institute for Assisted Reproduction6.15 Other Asia-Pacific IVF Market (Revenue and Number of Cycles)6.15.1 Number of IVF Cycles, 2014anddash;20216.15.2 Other Asia-Pacific IVF Market, 2014anddash;2021 ($Million)6.16 Other Asia-Pacific IVF Market by End Users6.16.1 Market Dynamics6.16.1.1 Drivers6.16.1.1.1 INCREASE IN DISPOSABLE INCOME6.16.1.1.2 ADVANCES IN IVF TECHNOLOGY6.16.1.1.3 DECLINE IN FERTILITY RATE6.16.1.2 Restraints6.16.1.2.1 PHYSICAL AND EMOTIONAL IMPACT DUE TO LOW SUCCESS RATE6.16.2 Regulatory Issues, legislations and Authorities6.16.3 Insurance Reimbursement Scenario6.16.4 Company Profiles6.16.4.1 Fertility Centre, Siloam Hospitals Surabana6.16.4.2 CRM-MIA-Philippines6.16.4.3 IVFASCHAPTER: 7 LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)7.1 Latin America IVF Market (Revenue and Number of Cycles)7.1.1 Number of IVF Cycles, 2014anddash;20217.1.2 Latin America IVF Market, 2014anddash;2021 ($Million)7.1.3 Number of Infertility Centers7.2 Latin America IVF Market by End users7.2.1 Market Dynamics7.2.1.1 Drivers7.2.1.1.1 RISING MEDICAL TOURISM IN LATIN AMERICAN COUNTRIES7.2.1.1.2 LIFTED ITS BAN ON IVF TREATMENTS IN COUNTRIES SUCH AS COSTA RICA7.2.1.2 Restraints7.2.1.2.1 HIGH INFANT MORTALITY RATES IN BRAZIL7.2.2 Regulatory Issues, legislations and Authorities7.2.3 Insurance Reimbursement Scenario7.2.4 Profiles of Major Players7.2.4.1 Clinica Anglo Americana7.2.4.2 IVF Panama Centro De Reproduccion7.2.4.3 Insemer7.2.4.4 Almater Hospital7.2.4.5 San Fernando Hospital7.3 Middle East IVF Market (Revenue and Number of Cycles)7.3.1 Middle East IVF Market, 2014anddash;2021 ($Million)7.3.2 Number of infertility centers7.4 Middle East IVF Market by End users7.4.1 Market Dynamics7.4.1.1 Drivers7.4.1.1.1 HIGH-TECH CULTURE IN THE MIDDLE EAST COUNTRIES7.4.1.1.2 WIDE AVAILABILITY OF REIMBURSEMENTS7.4.1.2 Restraints7.4.1.2.1 STRINGENT GOVERNMENT REGULATIONS IN MUSLIM MIDDLE EASTERN REGIONS7.4.2 Regulatory Issues, Legislations and Authorities7.4.3 Insurance Reimbursement Scenario7.4.4 Company Profile7.4.4.1 Cyprus IVF Centre7.4.4.2 Al Bushra Medical Specialty Complex7.4.4.3 Reproductive Medicine Unit at Corniche Hospital (Corniche Fertility center)7.4.4.4 Trakya University Hospital ART Center7.5 Africa IVF Market (Revenue and Number of Cycles)7.5.1 Number of IVF Cycles, 2014anddash;20217.5.2 Africa IVF Market, 2014anddash;2021 ($Million)7.5.3 Number of infertility centers7.6 Africa IVF Market by End users7.6.1 Market Dynamics7.6.1.1 Drivers7.6.1.1.1 LOW IVF TREATMENT COSTS7.6.1.1.2 RISING FERTILITY TOURISM IN SOUTH AFRICA7.6.1.2 Restraints7.6.1.2.1 SUSCEPTIBILITY TOWARD FIBROIDS7.6.2 Regulatory Issues, legislations and Authorities7.6.3 Insurance Reimbursement Scenario7.6.4 Company Profile7.6.4.1 Lifesure Fertility andamp; Gynaecology Centre7.6.4.2 Bethany Women and Family Hospital7.6.4.3 BioART Fertility Centre7.6.4.4 DEL International Hospital andamp; Fertility Centre7.6.4.5 Gift ov life7.6.4.6 Durban Fertility Clinic7.6.4.7 Cape fertility clinicandnbsp;LIST OF FIGURESFIG. 1 GLOBAL IVF MARKET, 2014 anddash; 2021 ($MILLION)FIG. 2 NUMBER OF GLOBAL IVF CYCLES, 2014 anddash; 2021 (THOUSAND)FIG. 3 REGULATORY SCENARIO, UNITED STATESFIG. 4 REGULATORY SCENARIO, CANADAFIG. 5 REGULATORY SCENARIO, MEXICOFIG. 6 REGULATORY SCENARIO, GERMANYFIG. 7 REGULATORY SCENARIO, FRANCEFIG. 8 REGULATORY SCENARIO, UNITED KINGDOMFIG. 9 TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)FIG. 10 CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)FIG. 11 TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)FIG. 12 TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)FIG. 13 IVF SUCCESS RATE FOR AUSTRALIAFIG. 14 TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)FIG. 15 TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) - SOUTH KOREAFIG. 16 THAILAND FERTILITY RATE CHILD BORN/WOMENFIG. 17 REGULATORY SCENARIO, LATIN AMERICAFIG. 18 EGULATORY SCENARIO, MIDDLE EASTFIG. 19 REGULATORY SCENARIO, AFRICALIST OF TABLESTABLE 1 NUMBER OF IVF CYCLES BY REGION, 2014-2021 (THOUSAND)TABLE 2 NUMBER OF IVF CYCLES BY REGION, 2014-2021 ($MILLION)TABLE 3 PRICING TRENDS BY COUNTRY, 2014TABLE 4 NUMBER OF IVF CYCLES BY COUNTRIES, 2014-2021 (THOUSAND)TABLE 5 GLOBAL IVF CYCLES BY END USER, 2014 anddash; 2021 (THOUSAND)TABLE 6 GLOBAL IVF REVENUE BY END USER, 2014 anddash; 2021 ($MILLION)TABLE 7 IVF SUCCESS RATES ACCORDING TO AGETABLE 8 NORTH AMERICA IVF CYCLES, andnbsp;2014 - 2021 (THOUSAND)TABLE 9 NORTH AMERICA IVF MARKET 2014 - 2021 ($MILLION)TABLE 10 FRESH EMBRYO TRANSFER FROM NON-DONOR OOCYTES, UNITED STATES, 2013TABLE 11 THAWED EMBRYO TRANSFER FROM NON-DONOR OOCYTES, UNITED STATES, 2013TABLE 12 DONOR OOCYTES (FOR ALL AGES), UNITED STATES, 2013TABLE 13 UNITED STATES IVF CYCLES, 2014 - 2021 (THOUSAND)TABLE 14 UNITED STATES IVF MARKET 2014 - 2021 ($MILLION)TABLE 15 NUMBER OF FERTILITY CLINICS IN UNITED STATES (2014)TABLE 16 UNITED STATES IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 17 UNITED STATES IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 18 FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEWTABLE 19 SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAYTABLE 20 CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEWTABLE 21 SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATESTABLE 22 SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEWTABLE 23 SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTETABLE 24 SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)BUSINESS OVERVIEWTABLE 25 SNAPSHOT OF INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)TABLE 26 CARDONE REPRODUCTIVE MEDICINE andamp; INFERTILITY BUSINESS OVERVIEWTABLE 27 SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE andamp; INFERTILITYTABLE 28 FERTILITY CENTER OF SAN ANTONIO BUSINESS OVERVIEWTABLE 29 SNAPSHOT OF FERTILITY CENTER OF SAN ANTONIOTABLE 30 HOUSTON FERTILITY CENTER BUSINESS OVERVIEWTABLE 31 SNAPSHOT OF HOUSTON FERTILITY CENTERTABLE 32 NEW HOPE FERTILITY CENTER BUSINESS OVERVIEWTABLE 33 SNAPSHOT OF HOUSTON FERTILITY CENTERTABLE 34 REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY BUSINESS OVERVIEWTABLE 35 SNAPSHOT OF HOUSTON FERTILITY CENTERTABLE 36 SUMMARY FOR IVF PROCEDURES, CANADA, 2012TABLE 37 CYCLE OUTCOMES FOR IVF PROCEDURES, CANADA, 2012TABLE 38 NUMBER OF IVF CYCLES, CANADA, 2014 - 2021 (THOUSAND)TABLE 39 CANADA IVF MARKET 2014 - 2021 ($MILLION)TABLE 40 CANADA IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 41 CANADA IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 42 BUSINESS OVERVIEWTABLE 43 SNAPSHOT OF TORONTO CENTRE FOR ADVANCED REPRODUCTIVE TECHNOLOGY LTD.TABLE 44 FERTILITY TREATMENT CENTER BUSINESS OVERVIEWTABLE 45 SNAPSHOT OF FERTILITY TREATMENT CENTERTABLE 46 FERTILITY TREATMENT CENTER BUSINESS OVERVIEWTABLE 47 SNAPSHOT OF FERTILITY TREATMENT CENTERTABLE 48 SUMMARY FOR IVF MARKET, MEXICO, 2010TABLE 49 NUMBER OF IVF CYCLES, MEXICO, 2014 - 2021 (THOUSAND)TABLE 50 MEXICO IVF MARKET 2014 - 2021 ($MILLION)TABLE 51 MEXICO IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 52 MEXICO IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 53 LIV FERTILITY CENTER IN PUERTO VALLARTA BUSINESS OVERVIEWTABLE 54 SNAPSHOT OF FERTILITY TREATMENT CENTERTABLE 55 BIOFERTILITY CENTER IN GUDALAJARA BUSINESS OVERVIEWTABLE 56 SNAPSHOT OF FERTILITY TREATMENT CENTERTABLE 57 NUMBER OF IVF CYCLES, EUROPE, 2014 - 2021 (THOUSAND)TABLE 58 EUROPE IVF MARKET 2014 - 2021 ($MILLION)TABLE 59 NUMBER OF IVF CYCLES, GERMANY, 2014anddash;2021 (THOUSAND)TABLE 60 GERMANY IVF MARKET 2014anddash;2021 ($MILLION)TABLE 61 GERMANY IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 62 GERMANY IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 63 HEIDELBERG UNIVERSITY HOSPITAL BUSINESS OVERVIEWTABLE 64 SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITALTABLE 65 KLINIKUM STUTTGART BUSINESS OVERVIEWTABLE 66 COMPANY SNAPSHOTTABLE 67 DRK KLINIKEN BERLIN BUSINESS OVERVIEWTABLE 68 SNAPSHOT OF DRK KLINIKEN BERLINTABLE 69 UNIVERSITY MEDICAL CENTER FREIBURG BUSINESS OVERVIEWTABLE 70 SNAPSHOT OF UNIVERSITY MEDICAL CENTER FREIBURGTABLE 71 NUMBER OF IVF CYCLES, FRANCE, 2014anddash;2021 (THOUSAND)TABLE 72 FRANCE IVF MARKET 2014anddash;2021 ($MILLION)TABLE 73 FRANCE IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 74 FRANCE IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 75 CLINIQUE DE LA MUETTE BUSINESS OVERVIEWTABLE 76 SNAPSHOT OF CLINIQUE DE LA MUETTETABLE 77 HOPITAL DES METALLURGISTS, HOPITAL COCHIN BUSINESS OVERVIEWTABLE 78 SNAPSHOT OF HOPITAL DES METALLURGISTS, HOPITAL COCHINTABLE 79 IVF CYCLES BY VARIOUS AGE GROUPS, UNITED KINGDOM, 2011TABLE 80 PROPORTION OF IVF CYCLES USING FRESH AND FROZEN EGGS, UNITED KINGDOM, 2010-2011TABLE 81 IVF SUCCESS RATES IN UNITED KINGDOM (AS PER NHS), 2010TABLE 82 REGIONAL IVF CLINICS AND TOTAL NUMBER OF WOMEN TREATED, UNITED KINGDOM, 2011TABLE 83 UNITED KINGDOM IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 84 UNITED KINGDOM IVF MARKET 2014anddash;2021 ($MILLION)TABLE 85 UNITED KINGDOM IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 86 UNITED KINGDOM IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 87 LISTER FERTILITY CLINIC BUSINESS OVERVIEWTABLE 88 COMPANY SNAPSHOTTABLE 89 THE BRIDGE CENTER BUSINESS OVERVIEWTABLE 90 SNAPSHOT OF THE BRIDGE CENTERTABLE 91 CHELSEA AND WESTMINSTER HOSPITAL BUSINESS OVERVIEWTABLE 92 SNAPSHOT OF CHELSEA AND WESTMINSTER HOSPITALTABLE 93 ITALY IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 94 ITALY IVF MARKET 2014anddash;2021 ($MILLION)TABLE 95 ITALY IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 96 ITALY IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 97 SPAIN IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 98 SPAIN IVF MARKET 2014anddash;2021 ($MILLION)TABLE 99 SPAIN IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 100 SPAIN IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 101 DENMARK, IVF CYCLES, andnbsp;2014anddash;2021 (THOUSAND)TABLE 102 DENMARK IVF MARKET 2014anddash;2021 ($MILLION)TABLE 103 DENMARK IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 104 DENMARK IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 105 RUSSIA IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 106 RUSSIA IVF MARKET 2014anddash;2021 ($MILLION)TABLE 107 RUSSIA IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 108 RUSSIA IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 109 OTHER EUROPE IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 110 OTHER EUROPE IVF MARKET 2014anddash;2021 ($MILLION)TABLE 111 OTHER EUROPE IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 112 OTHER EUROPE IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 113 NUMBER OF IVF CYCLES, ASIA-PACIFIC, 2014 - 2021 (THOUSAND)TABLE 114 ASIA-PACIFIC IVF MARKET 2014 - 2021 ($MILLION)TABLE 115 INDIA IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 116 INDIA IVF MARKET 2014anddash;2021 ($MILLION)TABLE 117 INDIA IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 118 INDIA IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 119 SUN PHARMACEUTICAL BUSINESS OVERVIEWTABLE 120 SNAPSHOT OF SUN PHARMACEUTICALTABLE 121 TRIVECTOR ORIGIO SCIENTIFIC BUSINESS OVERVIEWTABLE 122 SNAPSHOT OF TRIVECTOR ORIGIOTABLE 123 LAB IVF ASIA BUSINESS OVERVIEWTABLE 124 SNAPSHOT OF LAB IVF ASIATABLE 125 LG LIFE SCIENCE BUSINESS OVERVIEWTABLE 126 SNAPSHOT OF LG LIFE SCIENCETABLE 127 CADILA HEALTH CARE BUSINESS OVERVIEWTABLE 128 SNAPSHOT OF CADILA HEALTH CARETABLE 129 BOURN HALL BUSINESS OVERVIEWTABLE 130 SOUTHEND FERTILITY AND IVF CENTRE BUSINESS OVERVIEWTABLE 131 MORPHEUS IVF FERTILITY CENTER BUSINESS OVERVIEWTABLE 132 BLOOM FERTILITY CENTER BUSINESS OVERVIEWTABLE 133 MANIPAL ANKUR BUSINESS OVERVIEWTABLE 134 CLOUDNINE BUSINESS OVERVIEWTABLE 135 NOVA IVI FERTILITY BUSINESS OVERVIEWTABLE 136 CHINA IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 137 CHINA IVF MARKET 2014anddash;2021 ($MILLION)TABLE 138 CHINA IVF CYCLES BY END USERS, 2014anddash; 2021 (THOUSAND)TABLE 139 CHINA IVF MARKET REVENUE BY END USERS, 2014anddash; 2021 ($MILLION)TABLE 140 COOK MEDICAL INC BUSINESS OVERVIEWTABLE 141 SNAPSHOT OF COOK MEDICAL INC.TABLE 142 VITROLIFE AB INC., BUSINESS OVERVIEWTABLE 143 SNAPSHOT OF VITROLIFE AB INC.TABLE 144 REPRODUCTIVE AND GENETIC HOSPITAL CITIC-XIANGYA, BUSINESS OVERVIEWTABLE 145 SHENYANG HOSPITAL BUSINESS OVERVIETABLE 146 SHANDONG PROVINCIAL HOSPITAL BUSINESS OVERVIEWTABLE 147 CENTRE FOR REPRODUCTIVE MEDICINE, BUSINESS OVERVIEWTABLE 148 JAPAN IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 149 JAPAN IVF MARKET 2014anddash;2021 ($MILLION)TABLE 150 JAPAN IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 151 JAPAN IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 152 EMD SERONO INC BUSINESS OVERVIEWTABLE 153 SNAPSHOT OF EMD SERONO INCTABLE 154 IVF NAMBA CLINIC BUSINESS OVERVIEWTABLE 155 IWAKI WOMENandrsquo;S CLINIC BUSINESS OVERVIEWTABLE 156 SANNO HOSPITAL BUSINESS OVERVIEWTABLE 157 AUSTRALIA IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 158 AUSTRALIA IVF MARKET 2014anddash;2021 ($MILLION)TABLE 159 OUTCOMES OF CYCLES OF IVF BY WOMENandrsquo;S AGE GROUP, 2011TABLE 160 AUSTRALIA IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 161 AUSTRALIA IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 162 GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEWTABLE 163 SNAPSHOT OF GENEA BIOMEDX TECHNOLOGIESTABLE 164 SNAPSHOT OF THERMO FISHER SCIENTIFIC INC.TABLE 165 THERMO FISHER SCIENTIFIC INC. BUSINESS OVERVIEWTABLE 166 VIRTUS HEALTH BUSINESS OVERVIEWTABLE 167 MONASH IVF BUSINESS OVERVIEWTABLE 168 CITY FERTILITY BUSINESS OVERVIEWTABLE 169 FLINDERS FERTILITY BUSINESS OVERVIEWTABLE 170 NEW ZEALAND IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 171 NEW ZEALAND IVF MARKET 2014anddash;2021 ($MILLION)TABLE 172 NEW ZEALAND IVF REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 173 NEW ZEALAND IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 174 KOREA IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 175 NEW ZEALAND IVF MARKET 2014anddash;2021 ($MILLION)TABLE 176 KOREA IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 177 KOREA IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 178 THAILAND IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 179 THAILAND IVF MARKET 2014anddash;2021 ($MILLION)TABLE 180 THAILAND IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 181 THAILAND IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 182 OTHER ASIA-PACIFIC IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 183 OTHER ASIA-PACIFIC IVF MARKET 2014anddash;2021 ($MILLION)TABLE 184 OTHER ASIA-PACIFIC IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 185 OTHER ASIA-PACIFIC IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 186 LAMEA IVF CYCLES, 2014 - 2021 (THOUSAND)TABLE 187 LAMEA IVF MARKET 2014 - 2021 ($MILLION)TABLE 188 LATIN AMERICA IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 189 LATIN AMERICA IVF MARKET 2014anddash;2021 ($MILLION)TABLE 190 LATIN AMERICA IVF CYCLES BY END USERS, 2014anddash; 2021 (THOUSAND)TABLE 191 LATIN AMERICA IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 192 CLINICA ANGLO AMERICANA BUSINESS OVERVIEWTABLE 193 SNAPSHOT OF CLINICA ANGLO AMERICANATABLE 194 IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA BUSINESS OVERVIEWTABLE 195 SNAPSHOT OF IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICATABLE 196 INSAMER BUSINESS OVERVIEWTABLE 197 COMPANY SNAPSHOTTABLE 198 ALMATER HOSPITAL BUSINESS OVERVIEWTABLE 199 COMPANY SNAPSHOTTABLE 200 SAN FERNANDO HOSPITAL BUSINESS OVERVIEWTABLE 201 COMPANY SNAPSHOTTABLE 202 MIDDLE EAST IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 203 MIDDLE EAST IVF MARKET 2014anddash;2021 ($MILLION)TABLE 204 MIDDLE EAST IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 205 MIDDLE EAST IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 206 CYPRUS IVF CENTRE BUSINESS OVERVIEWTABLE 207 COMPANY SNAPSHOTTABLE 208 AL BUSHRA MEDICAL SPECIALTY COMPLEX BUSINESS OVERVIEWTABLE 209 COMPANY OF AL BUSHRA MEDICAL SPECIALTY COMPLEXTABLE 210 REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL BUSINESS OVERVIEWTABLE 211 SNAPSHOT OF REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITALTABLE 212 TRAKYA UNIVERSITY HOSPITAL ART CENTER BUSINESS OVERVIEWTABLE 213 SNAPSHOT OF TRAKYA UNIVERSITY HOSPITAL ART CENTERTABLE 214 AFRICA IVF CYCLES, 2014anddash;2021 (THOUSAND)TABLE 215 AFRICA IVF MARKET 2014anddash;2021 ($MILLION)TABLE 216 AFRICA IVF CYCLES BY END USERS, 2014 anddash; 2021 (THOUSAND)TABLE 217 AFRICA IVF MARKET REVENUE BY END USERS, 2014 anddash; 2021 ($MILLION)TABLE 218 LIFESURE FERTILITY andamp; GYNAECOLOGY CENTRE BUSINESS OVERVIEWTABLE 219 COMPANY SNAPSHOTTABLE 220 BETHANY WOMEN AND FAMILY HOSPITAL BUSINESS OVERVIEWTABLE 221 COMPANY SNAPSHOTTABLE 222 BIOART FERTILITY CENTRE BUSINESS OVERVIEWTABLE 223 COMPANY SNAPSHOTTABLE 224 DEL INTERNATIONAL HOSPITAL andamp; FERTILITY CENTRE BUSINESS OVERVIEWTABLE 225 COMPANY SNAPSHOTTABLE 226 GIFT OV LIFE BUSINESS OVERVIEWTABLE 227 COMPANY SNAPSHOTTABLE 228 DURBAN FERTILITY CLINIC BUSINESS OVERVIEWTABLE 229 COMPANY SNAPSHOTTABLE 230 CAPE FERTILITY CLINIC BUSINESS OVERVIEWTABLE 231 COMPANY SNAPSHOT

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...


Download Unlimited Documents from Trusted Public Sources

Medical Facility Industry in the UK and the US

  • December 2016
    13 pages
  • Medical Facilit...  

  • United Kingdom  

    United States  

View report >

Hospital Industry in South Africa

  • December 2016
    28 pages
  • Hospital  

    Insurance Indic...  

  • South Africa  

View report >

Housing Industry in the US

  • December 2016
    2 pages
  • Multifamily Hou...  

    Housing  

  • United States  

View report >

Hospital Markets

4 days ago

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.